The United Kingdom has become this Monday the first country to approve Moderna’s bivalent vaccine for people over 18 years of age, developed to attack the original COVID-19 virus – like the ones used right now – and the new omicron variant , as reported by the Medicines and Healthcare Products Regulatory Agency (MHRA).
With this decision, the vaccine is expected to be used as a booster for adults next fall, although the number of doses that are available is unknown at this time.
The health authorities had already indicated that – starting next September – a booster vaccine will be offered to those over 50 years of age and to people who are in the highest risk groups.
www.eldiario.es